Cargando…
Anti-TWEAK Antibody Alleviates Renal Interstitial Fibrosis by Increasing PGC-1α Expression in Lupus Nephritis
PURPOSE: Current studies on the mechanism of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in lupus nephritis (LN) mainly focus on the inflammatory pathway. Herein, we aimed to determine whether TWEAK could promote the progression of renal interstitial fibrosis by regulating peroxisom...
Autores principales: | Xue, Leixi, Zhang, Yi, Xu, Jiajun, Lu, Wentian, Wang, Qing, Fu, Jinxiang, Liu, Zhichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009537/ https://www.ncbi.nlm.nih.gov/pubmed/33814923 http://dx.doi.org/10.2147/JIR.S301356 |
Ejemplares similares
-
Iguratimod alleviates tubulo-interstitial injury in mice with lupus
por: Xue, Leixi, et al.
Publicado: (2022) -
TWEAK: a novel biomarker for lupus nephritis?
por: Dhaun, Neeraj, et al.
Publicado: (2009) -
Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis
por: Wilson, Parker C, et al.
Publicado: (2018) -
Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022) -
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Accelerates the Progression of Renal Fibrosis in Lupus Nephritis by Activating SMAD and p38 MAPK in TGF-β1 Signaling Pathway
por: Liu, Zhiqin, et al.
Publicado: (2016)